MedPath

EDARBYCLOR

EDARBYCLOR

Approved
DIN Number

02397749

Drug Class

Human

Market Date

Mar 21, 2013

Company
HC

bausch health, canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02397749
AIG Number0253470002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)Active
Strength: 40 MG
Monograph: AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
CHLORTHALIDONEActive
Strength: 12.5 MG
Monograph: CHLORTHALIDONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.